Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
A recent essay in Express Pharma by Mr. S. Swaminathan, CEO of GS1 India, extol...
ERS Genomics Limited (‘ERS’), the CRISPR licensing company, announced that it h...
Corporate history is replete with examples of the ‘third generation curse’, but...
The authorisation allows both treatments to be used for patients with primary hy...
The company said programmes could be onboarded at the facility immediately, rath...
The pharmaceutical industry is increasingly focusing on integrating Green and S...
BDR Pharmaceuticals International Pvt Ltd has announced the appointment of Nira...
For much of the past two decades, global biotech leadership has clustered aroun...
Like previous editions, the Summit will focus on practical perspectives, peer l...
Andelyn Biosciences, a leading and patient-focused cell and gene therapy Contra...
The Australian company will pay $1.65bn upfront on a cash-free, debt-free basis....
The candidate is in early-stage development and references Hemlibra (emicizumab)...
The conversation around environmental sustainability in the pharma industry is ...
Akums Drugs & Pharmaceuticals has announced the development of a DCGI-approved ...
Biocon Biologics announced that the Committee for Medicinal Products for Human ...
The pharmaceutical industry has invested heavily in digitisation over the past f...